Abstract: Neurofibromatosis type 1 is a multisystem genetic disease of autosomal dominant transmission that reveals important cutaneous manifestations such as café-au-lait spots, multiple neurofibromas, and ephelides in skin fold areas, as well as hamartomatous lesions in the eyes, bones, glands, and central nervous system. Moyamoya disease is a rare progressive vaso-occlusive disorder that occurs with important ischemic cerebrovascular events. Despite the rarity of this association in childhood, children diagnosed with neurofibromatosis type 1 and focal neurologic symptoms should be investigated for moyamoya syndrome. The present study reports the case of a pediatric patient with a rapidly progressive cerebrovascular accident and a late diagnosis of Neurofibromatosis type 1 associated with moyamoya disease.
INTRODUCTION
Neurofibromatosis type 1 (NF-1), or von Recklinghausen's disease, is a multisystem genetic disease of autosomal dominant transmission. It is caused by a decrease in the production of the neurofibromin protein due to mutations in the NF1 gene, located on the long arm of chromosome 17 (17q11.2), resulting in a lack of control of cell growth and division. It presents with important cutaneous manifestations, such as café-au-lait spots, multiple neurofibromas, and ephelides in skin folds, as well as hamartomatous lesions in the eyes, bones, glands, and central nervous system (CNS). The incidence of NF-1 is 1/2,500 live births, regardless of race and gender.
It is estimated that there are 80,000 cases of NF-1 in Brazil and 1.5 million cases worldwide. generating a characteristic diagnostic pattern on cerebral angiography similar to a "hazy puff of smoke" (moyamoya, in Japanese). 3, 4 The association between NF-1 and vascular changes is not uncommon. However, its association with specific cerebrovascular diseases, such as MMD, is rarely observed. 5, 6 The present study reports the case of a non-Asian preschooler with ischemic and rapidly progressive cerebrovascular accident (CVA), compatible with MMD, associated with a late diagnosis of NF-1. and VII) a first-degree relative diagnosed with NF-1 following these criteria. Our patient fulfilled two of the diagnostic criteria, confirming the diagnosis of NF-1.
MMD is a severe disease that may evolve with an unfavorable neurological course. In patients with NF-1 associated with MMD, early diagnosis and appropriate surgical treatment are of extreme importance both to improve cerebral hemodynamics and to reduce the incidence of new ischemic events. 8 The association of MMD with other diseases has also been described, such as renovascular disease, aneurysms of the circle characteristic cerebrovascular changes occur associated with one of these diseases. However, when they occur isolatedly and idiopathically, the term adopted is moyamoya disease. 1, 4 Other authors consider that the characteristic arteriographic changes are bilateral in patients with moyamoya disease, while they are unilateral in moyamoya syndrome. The term "moyamoya", when used alone, refers only to arteriographic changes, regardless of the cause. 4 Therefore,
we defined the present case, according to this classification, as moyamoya syndrome.
Despite the proximity of the NF1 gene (17q11.2) to the familial moyamoya disease gene (17q25), the participation of the NF1 gene in the occurrence of MMD is controversial. 8 As observed in this case, the clinical characteristics in children mainly involves ischemic events such as transient ischemic attacks and ischemic strokes, as well as focal seizures with headache and intracranial hemorrhage.
In adults, events tend to be hemorrhagic. 3, 8 In NF-1, most patients with vascular lesions linked to the disease itself are asymptomatic. Present symptoms include paraesthesia, headache, status epilepticus, hemianopsia, nystagmus, aphasia, dysphasia, and borderline mental functioning. 8, 9 The treatment of choice for patients with MMD is still surgical intervention, especially surgical revascularization, which aims to increase blood flow to the cortex hypoperfused by occlusions. 4, 8, 10 Although the association described herein is unusual, MMD is a potentially severe condition with a reserved neurological course of prognosis. The hypothesis of this association should be considered in patients with NF-1 who present with focal neurological symptoms, mainly because these can be confused with the neurological manifestations related to this disease. Thus, early therapy is essential to avoid or minimize irreversible sequelae. q
